[Clinical experience with Ophtovitol].
D000241:Adenosine / Q000627:therapeutic use*; D000328:Adult; D000731:Androstanes / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003231:Conjunctivitis / Q000188:drug therapy*; D065306:Corneal Injuries; D004338:Drug Combinations; D005126:Eye Burns / Q000188:drug therapy; D005131:Eye Injuries / Q000188:drug therapy; D006801:Humans; D007634:Keratitis / Q000188:drug therapy; D007637:Keratoconjunctivitis / Q000188:drug therapy; D008297:Male; D009824:Ointments; D010205:Pantothenic Acid / Q000627:therapeutic use*; D012256:Riboflavin / Q000627:therapeutic use*; D014801:Vitamin A / Q000627:therapeutic use
D000731:Androstanes; D004338:Drug Combinations; D009824:Ointments; D014801:Vitamin A; D010205:Pantothenic Acid; D000241:Adenosine; D012256:Riboflavin
Klinische Erfahrungen mit Ophtovitol.